Insights

Gathering insights about OIV…

Similar companies to OIV

OIV Tech Stack

OIV uses 8 technology products and services including Google Analytics, Facebook Pixel, Mailchimp, and more. Explore OIV's tech stack below.

Google Analytics
Analytics
Facebook Pixel
Analytics
Mailchimp
Email
jQuery
Javascript Libraries
Google Maps
Maps
Open Graph
Miscellaneous
Windows Server
Operating Systems
IIS
Web Servers

Media & News

Roivant Sciences: A Biotech Growth Play With Major Ambitions
Roivant Sciences leverages its "Vant" model to develop and monetize drug candidates through subsidiaries, ensuring rapid advancement in therapeutic pipelines. Late-stage assets like Brepocitinib, IMVT-1402, and Mosliciguat position Roivant for significant clinical and commercial milestones by 2025. Strategic divestitures, like Dermavant's sale to Organon for $1.2 billion, support shareholder value through share buybacks and bolster financial stability.
Dec 04, 2024 | seekingalpha.com
Roivant's lung disease drug fails mid-stage trial
Roivant said on Tuesday its drug did not meet the main goal in a mid-stage trial evaluating it in patients with a type of lung disease.
Dec 03, 2024 | www.reuters.com
Roivant Sciences Ltd. (ROIV) Q2 2024 Earnings Call Transcript
Roivant Sciences Ltd. (NASDAQ:ROIV ) Q2 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Stephanie Lee - Investor Relations Matt Gline - Chief Executive Officer Ben Zimmer - Chief Executive Officer, Priovant Conference Call Participants Louise Chen - Cantor Brian Cheng - JPMorgan Joyce Zhou - TD Cowen Andy Chen - Wolfe Research Douglas Tsao - H.C.
Nov 12, 2024 | seekingalpha.com
Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Misses Revenue Estimates
Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.21.
Nov 12, 2024 | www.zacks.com
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024
BASEL, Switzerland and LONDON and NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, November 12, 2024, to report its financial results for the second quarter ended September 30, 2024, and provide a business update.
Oct 29, 2024 | www.globenewswire.com
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
The acquisition expands Organon's dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S. The acquisition expands Organon's dermatology capabilities with a nonbiologic, non-steroidal topical treatment in the U.S.
Oct 28, 2024 | www.globenewswire.com
Roivant Sciences: Good Value, But Near-Term Catalysts Could Bring Volatility
Roivant's high valuation stems from its strong cash position, promising drug pipeline, Techbio assets, and strategic partnerships, making it a compelling buy. Recent sales of Telavant and Dermavant have bolstered Roivant's cash reserves. Key potential catalysts include Immunovant's batoclimab in Phase 3 trials and namilumab in a Phase 2 trial, though drug candidate performance remains a critical risk factor.
Oct 22, 2024 | seekingalpha.com

OIV's Email Address Formats

OIV uses at least 1 format(s):

OIV Email Formats	Example	Percentage
First.Last@oiv.hr	John.Doe@oiv.hr	46%
FirstLast@oiv.hr	JohnDoe@oiv.hr	4%
FirstL@oiv.hr	JohnD@oiv.hr	4%
First.Last@oiv.hr	John.Doe@oiv.hr	46%

Frequently Asked Questions

Where is OIV's headquarters located?

OIV's main headquarters is located at Ulica grada Vukovara 269d Zagreb, HR 10000 HR. The company has employees across 5 continents, including EuropeSouth AmericaNorth America.

What is OIV's phone number?

You can contact OIV's main corporate office by phone at

+385-1-6186****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OIV's stock symbol?

OIV is a publicly traded company; the company's stock symbol is ROIV.

What is OIV's official website and social media links?

OIV's official website is oiv.hr and has social profiles on LinkedIn.

What is OIV's NAICS code?

OIV's NAICS code is 515 - Broadcasting (except Internet).

How many employees does OIV have currently?

As of May 2021, OIV has approximately 201 employees across 5 continents, including EuropeSouth AmericaNorth America. Key team members include Head Of Corporate Security Department: K. Č.Head Of Sales Department: M. S.Head Of Transmission Network Department: M. I.. Explore OIV's employee directory with LeadIQ.

What industry does OIV belong to?

OIV operates in the Broadcast Media Production and Distribution industry.

What technology does OIV use?

OIV's tech stack includes Google AnalyticsFacebook PixelMailchimpjQueryGoogle MapsOpen GraphWindows ServerIIS.

What is OIV's email format?

OIV's email format typically follows the pattern of . Find more OIV email formats with LeadIQ.

When was OIV founded?

OIV was founded in 2002.

OIV

Broadcast Media Production and DistributionHR, Croatia201-500 Employees

With more than 90 years of tradition and experience Transmitters and Communications Ltd. (OIV) operates in the core of broadcasting and telecommunication industries, providing complete radio and television broadcasting services, audio-visual content and data distribution, fibre-optic lease, co-location as well as modern media services. 

S više od 90 godina tradicije i iskustva Odašiljači i veze d.o.o. (OIV) djeluju na području radiokomunikacija i telekomunikacija, pružajući cjelovite usluge odašiljanja radijskih i televizijskih programa, prijenosa slike, zvuka i podataka, zakupa svjetlovoda, kolokacije i suvremene multimedijske usluge.